Ke Wei
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Circular RNAs in diseases 6
- Extracellular vesicles in disease 5
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 6
- Co-authors
- Fengming Yang (6 shared papers)Chuchu Shao (2 shared papers)Mengyan Xie (2 shared papers)Xinming Jing (1 shared paper)Hua Shen (1 shared paper)Glenn D. Rosen (7 shared papers)Chunfeng Pan (13 shared papers)Yang Xia (11 shared papers)
- Journals
- Cellular Physiology and Biochemistry (4 papers)Fish & Shellfish Immunology (3 papers)Cell Death and Disease (3 papers)Free Radical Biology and Medicine (2 papers)Developmental Dynamics (2 papers)
- Partner nations
- ChinaUnited StatesIreland
In The Last Decade
Ke Wei
58 papers receiving 3.3k citations
Ke Wei's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.2k
- Complementary and alternative medicine 208
- Molecular Biology 1.6k
- Molecular Medicine 81
- Immunology 331
Countries citing papers authored by Ke Wei
This map shows the geographic impact of Ke Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Wei more than expected).
Fields of papers citing papers by Ke Wei
This network shows the impact of papers produced by Ke Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Wei. The network helps show where Ke Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of hypoxia in cancer therapy by regulating the tumor microenvironment Hit paper breakdown → | 2019 | 1489 |
| 2 | 2001 | 145 | |
| 3 | 2021 | 111 | |
| 4 | PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. | 2003 | 102 |
| 5 | 2010 | 89 | |
| 6 | 2021 | 86 | |
| 7 | 2018 | 78 | |
| 8 | 2015 | 72 | |
| 9 | 2022 | 72 | |
| 10 | 2018 | 56 | |
| 11 | 2017 | 52 | |
| 12 | 2022 | 51 | |
| 13 | 2017 | 50 | |
| 14 | 2020 | 48 | |
| 15 | 2014 | 48 | |
| 16 | 2020 | 48 | |
| 17 | 2008 | 46 | |
| 18 | 2016 | 43 | |
| 19 | 2012 | 42 | |
| 20 | 2019 | 40 |
About Ke Wei
Ke Wei is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Oncology, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (5 papers), Extracellular vesicles in disease (5 papers), RNA modifications and cancer (4 papers), Vibrio bacteria research studies (3 papers) and Natural Compounds in Disease Treatment (3 papers). The work is most often cited by research in Cancer Research (1.2k citations), Complementary and alternative medicine (208 citations), Molecular Biology (1.6k citations), Molecular Medicine (81 citations) and Immunology (331 citations). Ke Wei has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Fengming Yang, Chuchu Shao, Mengyan Xie, Xinming Jing, Hua Shen, Glenn D. Rosen, Chunfeng Pan, Yang Xia, Wenteh Chang and Jessica A. Ross. Their work appears in journals such as Cellular Physiology and Biochemistry, Fish & Shellfish Immunology, Cell Death and Disease, Free Radical Biology and Medicine and Developmental Dynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.